Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Friday! It's October 14th. Let's get ready to trade! Markets ð US benchmarks recovered from the shock of a hotter-than-expected Sept. CPI report to post sharp gains for the session. The Dow rallied 2.8%, and the S&P 500 jumped 2.6%. The tech-heavy Nasdaq spiked 2.2%, and the small-cap Russell 2K added 2.4%. Today, futures are up again in the premarket. The S&P 500 futures are up 0.4% in early-morning trading. Sponsored
[The Dark Secret of the Energy Industry]( â¡ Most people donât know this⦠But sixty percent of the energy thatâs generated each year in America is wasted. Thatâs right â sixty percent! Yet a tiny Silicon Valley company has just discovered how to use AI to tap this trillion-dollar treasure trove of wasted energy ⦠and turn it into power we can use⦠Meaning this companyâs growth could be almost unimaginable⦠[Get the Details on This Enormous Opportunity Here]( Premarket Highlights ð - Mortgage-rates set a new 20-year high yesterday after the average rate on a fixed 30-year mortgage rose to 6.92%.
- Sept. CPI outpaced economists' expectations with a 8.2% year-on-year increase. Core CPI rose 6.6% from last year. What to Watch Today ð Bull Trap? Investors freaked out when the CPI report hit the wires during yesterday's premarket, but stocks quickly recovered to post sharp gains for the today. This morning, futures are up again, but is this rally for real or just a flash in the pan? I'm not so certain, but I can tell you that I don't think the downturn has bottomed out just yet. Enjoy the gains while they last. International ð Asia Japana's Nikkei 225 broke out to a 3.2% gain overnight, as Asian markets reacted to yesterday's big rally in the US. The Shanghai Composite gained 1.8% in China, and the Australian ASX 200 jumped 1.7%. Europe
The UK FTSE 100 and the German DAX are both showing 1.2% gains midway through the European trading session, and the French CAC 40 is up 1.5%. The Euro Stoxx 600 is showing a 1.4% gain. Major Earnings ð° United Health [UNH] ... AM
JPMorgan Chase [JPM] ... AM
Wells Fargo Corp. [WFC] ... AM
Morgan Stanley [MS] ... AM
Citigroup [C] ... AM
PNC Fiinancial [PNC] ... AM
US Bancorp [USB] ... AM
First Republic Bank [FRC] ... AM Economy ð - Retail Sales [Sep] ... 8:30a
- Import Price Index [Sep] ... 8:30a
- UMich Consumer Sentiment ... 10a
- Business Inventories [Aug] ... 10a Running Hot ð¥ Gainers
- Zovio Inc [VO] >> +29.3%
- Connexa Sports Tech [CNXA] >> +60.1%
- Taoping [TAOP] >> +23.6% Decliners
- Novo Integrated Sciences [NVOS] >> (52.4%)
- Nuwellis Inc [NUWE] >> (18.8%)
- Liquid Meida [YVR] >> (16.8%) Delta Air Lines [DAL] - Last Close: $30.38 Delta is trending after releasing its earnings report yesterday. On Thursday, Delta missed analyst's targets for both earnings and revenues, but comments from the CEO sent shares higher regardless. CEO Ed Bastion said sales have remained strong into Sept., and he sees nothing that makes him think "that this momentum won't continue." Delta generated adjusted EPS of $1.51 for Q3 and revenues of $14.0 billion, which slightly missed analysts estimates. DAL made solid gains on Thursday, and it's leading the S&P 500 with a 2.9% gain on active trading volume. My Take: The airline industry sounds like it's in decent shape, despite soaring ticket prices and labor issues. Nonetheless, it's always tough to pick winners in this highly competitive industry. Imara Inc [IMRA] - Last Close: $2.58 A merger announcement is lifting shares of Imara Inc in today's premarket. Late Thursday, the clinical-stage biopharma firm announced it will merge with Enliven Therapeutics in an all-stock deal. The combined company is expected to have $300 million in cash and cash equivalents upon closing, and it will prioritize advancing Enliven's pipeline. The newly-formed company will operate under the name Enliven Therapeutics, and it's shares will trade on the Nasdaq Global Select Market under the ticker symbol ELVN. IMRA is on of this morning's most active stocks, and it's up 29.8% on the news. My Take: Enliven has a promising drug pipeline, so the merger instantly made IMRA more valuable. Share prices have been trending sideways since Sept., but this could be the catalyst it needs to break out. Laser Photonics Corp [LASE] - Last Close: $4.13 Laser Photonics is on our list for a third time this week, with more gains in today's premarket. The industrial laser-maker was already running red-hot after landing deals with two major institutions this week, the US Navy and Coca-Cola [KO]. Today, Laser Photonics announced it's launching an aggressive hiring campaign in response to the sharp increase in sales leads and inquiries. The company also said it plans to invest in marketing, operations, and engineering to drive growth. LASE up 26.6%, and it's one of this morning's highest-volume trades. My Take: This might be the first time that a stock has been on our list three times in a week. LASE is absolutely on fire, but this rally can't last forever. If you like this stock, sorry to say, you're late to the party. You might be better off waiting for a pullback before you dive into this one. EarGo [EAR] - Last Close: $0.71 EarGo is up on the heels of a regulatory filing. The hearing-focused medical device company filed Form FWP to set the record date for a proposed rights offering at Oct. 24th. On that date, existing EAR shareholders will have the opportunity to purchase more shares of the stock. EarGo intends to raise up to $187.5 million in aggregate gross proceeds from the rights offering, which the company first proposed on Aug. 25th. The Company expects to use a substantial portion of the proceeds from the proposed Rights Offering to repay the outstanding notes issued to Patient Square Capital at a premium. EAR shot to a 16.5% gain on the news, but it gave back some of its gains. The stock is currently up 8.5% on active trading volume. My Take: Investors seem to support EAR's plan to pay off some of its debts through a rights offering. However, the stock's chart is pretty ugly, and I'm worried it could see a big pullback next week. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or Text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL
Orlando FL 32828
USA [Unsubscribe]( | [Change Subscriber Options](